The "Cytokine Market - Growth, Trends, and Forecasts (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.
Cytokines are molecular messengers that allow the cells of the immune system to communicate with one another, to generate a coordinated, robust, but self-limited response to a target antigen.
There are two types of cytokines used to treat patients with cancer, namely, interferons (INFs) and interleukins (ILs). A third type, called hematopoietic growth factors, is used to counteract some of the side effects of certain chemotherapy regimens.
Novartis International AG
Johnson and Johnson
Key Market Trends
Application in Cancer is Expected to Hold the Largest Share of the Market
The mixture of cytokines that are produced in the cancer microenvironment has an important role in cancer pathogenesis. Cytokines that are released in response to infection, inflammation, and immunity can function to inhibit cancer development and progression. Alternatively, cancer cells can respond to host-derived cytokines that promote growth, attenuate apoptosis, and facilitate invasion and metastasis. To circumvent these impediments, cytokines are have been investigated clinically with new engineered cytokine mutants (superkines), chimeric antibody-cytokine fusion proteins (immunokines), anticancer vaccines, checkpoint inhibitors, and cancer-directed monoclonal antibodies to increase their antibody-dependent cellular cytotoxicity or sustain cellular responses and anticancer efficacy.
Moreover, the demand for this therapy is expected to increase as Cancer Research UK suggests that the population suffering from cancer is expected to increase across the globe in the future. As per the report, if recent trends in incidence of major cancers and population growth are consistent, it is predicted there will be 27.5 million new cancer cases worldwide each year by 2040, as compared to 17 million in 2018. This factor is, hence, expected to help the market growth.
North American Region Holds the Largest Market Share of the Cytokine Market
North America is dominating the cytokine market, due to the rising prevalence of cancer in the region. Numerous animal tumour model studies have demonstrated that cytokines have broad anti-tumour activity, which has been translated into a number of cytokine-based approaches for cancer therapy. As per the American Cancer Society, there were an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the United States, numbers which are expected to rise in future. Augmenting growth in the R&D of cancer therapy, along with lesser side effects (as compared to chemotherapy), has predisposed cytokine therapy, which is a non-specific immunotherapy. This factor has increased the market share of cytokines among cancer therapies, in the United States.
Key Topics Covered:
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increased Acceptance in Cancer Therapy
4.2.2 Use of Cytokine as a Potential Biomarker for Neonatal Sepsis
4.2.3 Potential Contribution in Stem Cell Therapy
4.3 Market Restraints
4.3.1 High Costs
4.3.2 Lacks Specificity
4.4 Porter's Five Forces Analysis
5 MARKET SEGMENTATION
5.1 By Cytokine Type
5.1.1 Tumor Necrosis Factor-TNF
5.1.4 Epidermal Growth Factor-EGF
5.1.5 Other Cytokine Types
5.2 By Therapeutic Application
5.2.2 Asthma and Airway Inflammation
5.2.4 Other Therapeutic Applications
5.3.1 North America
5.3.4 Middle-East & Africa
5.3.5 South America
6 COMPETITIVE LANDSCAPE
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
For more information about this report visit https://www.researchandmarkets.com/r/fv2461
View source version on businesswire.com: https://www.businesswire.com/news/home/20210122005229/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900